Abbott Laboratories News

Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide.

So what : For largely experimental research and development biotech companies, earnings reports tend to not have a huge effect on the price of the stock; today is a rare exception.

Stock trading strategies can vary greatly for investors at different stages of their careers.

NEW YORK &#8212 Shares of some top medical devices companies are mixed at 1 p.m.: Abbott Laboratories rose $.40 or .7 percent, to $55.40. Allergan rose $.37 or .4 percent, to $86.45. C.R. Bard Inc.

Rainbow Biosciences, the biotech division of Rainbow Coral Corp. , announced today that it's on the cusp of a major breakthrough in its business relationship with n3D Biosciences.

All signs point to emerging biotech company Rainbow Coral Corp. finding its feet in biotechnology at exactly the right time: The biotech industry is off to a great start in the early stages of 2012.

Let's examine the fundamental reasons first, then the chart technicals for why I think GlaxoSmithKline looks poised to break to a new 52-week high.

NEW YORK &#8212 Shares of some top medical devices companies are mixed at 10 a.m.: Abbott Laboratories fell $.64 or 1.2 percent, to $54.39. Allergan fell $1.33 or 1.5 percent, to $87.49. C.R. Bard Inc.

Cutting-edge stem cell research is producing new breakthroughs that could potentially revolutionize the treatment of currently incurable diseases from cancer to brain injuries to headaches.

The Drugs for Neglected Diseases initiative and Abbott have signed a four-year joint research and non-exclusive licensing agreement to undertake research on new treatments for several of the world's most neglected tropical diseases, including Chagas disease, helminth infections, leishmaniasis and sleeping sickness.

Abbott Laboratories 's stock had its "neutral" rating reiterated by Zacks Investment Research in a research note issued on Friday.

Divestitures became a major 2011 strategy as some of America's biggest blue chip stocks like Kraft Foods , ConocoPhillps , Abbott Laboratories , Northrop Grumman , Tyco and Marathon Oil spun assets to unlock value in their shares.

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the Proshares Ultra S&P500 where we have detected an approximate $72.8 million dollar outflow - that's a 4.2% decrease week over week .

Bank of America Corporation A : FINRA announced that it has fined Merrill Lynch, Pierce, Fenner & Smith $1M for failing to arbitrate disputes with employees relating to retention bonuses.

Diversified healthcare giant Abbott closed out 2011 with sales and operating profit growth slightly above its average annual trends over the past decade.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Medical device and drugmaker Abbott Laboratories said Wednesday it will lay off 700 employees as part of ongoing restructuring efforts.

Though the loss of patent protection on a brand-name prescription drug tends to lead to a sharp drop in sales for that product in the United States, such older medicines have become a booming business for the pharmaceutical industry in emerging markets.

NEW YORK &#8212 Shares of some top medical devices companies are mixed at 1 p.m.: Abbott Laboratories fell $1.23 or 2.2 percent, to $54.75. Allergan rose $.46 or .5 percent, to $88.95. C.R. Bard Inc.

From high dividend yields to low betas, biotech provides some of the strongest risk/reward opportunities.

THE LAYOFFS: Medical device and drugmaker Abbott Laboratories said Wednesday it will lay off 700 employees as part of ongoing restructuring efforts.